Trials / Recruiting
RecruitingNCT06910631
Optimizing the Care Pathway of Febrile Children Via Capillary C-reactive Protein Assay in Primary Care
Optimisation du Parcours de Soins Des Enfants fébriles Par l'Utilisation de la CRP Capillaire en Soins Primaires : Protocole d'un Essai Multicentrique randomisé
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 420 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 3 Months – 15 Years
- Healthy volunteers
- Not accepted
Summary
Fever is the leading reason for outpatient consultations among children aged 2 to 9 years. The main concern in fever is severe bacterial infection, particularly for younger children. History and clinical examination do not always differentiate viral infections from bacterial infection. In 20% of febrile children, no infectious focus is found after examination and additional tests are necessary. The first one is measuring C-reactive protein (CRP). The results are obtained in several hours on an outpatient basis, causing long delays before starting treatment and often requiring telephone calls or further consultations. Emergency room use is constantly increasing, generating growing tensions within healthcare facilities, yet a large number of visits are avoidable. Among children visiting the pediatric emergency room, parents reported being referred by their primary care physician in approximately 20% of cases for children aged 1 to 5 years and in 30% of cases for children under one year old. The use of capillary medical device to measure CRP in primary care could reduce this referral rate and help relieve overcrowding in emergency rooms, as well as unscheduled consultation centers and medical analysis laboratories. This would result in a streamlined care pathway, saving time for both physicians and patients, as well as reducing the cost of care for the healthcare system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Capillary CRP | CRP measured semi-quantitatively using ACTIM-CRP device |
Timeline
- Start date
- 2025-09-15
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2025-04-04
- Last updated
- 2025-11-19
Locations
16 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06910631. Inclusion in this directory is not an endorsement.